Lv5
950 积分 2024-05-28 加入
How low can you go?: Methodologic considerations in clonal hematopoiesis variant calling
8天前
已完结
Pan-tumor harmonization of pathologic response assessment for standardized data collection in neoadjuvant trials (PATHdata): Results of a Society for Immunotherapy of Cancer multi-institutional reproducibility study
2个月前
已关闭
Data integration: exploiting ratios of parameter estimates from a reduced external model
3个月前
已关闭
Clonal Hematopoiesis and Risk of Incident Lung Cancer
3个月前
已完结
Peri-operative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small cell lung cancer: final analysis of the randomized RATIONALE-315 trial
3个月前
已完结
Response to Immune Checkpoint Blockade is Enhanced in the Presence of Hematopoietic TET2 Inactivation
4个月前
已完结
Machine learning–based penetrance of genetic variants
4个月前
已完结
Tumor-Infiltrating Clonal Hematopoiesis
5个月前
已完结
Linear biomarker combination for constrained classification
6个月前
已完结
Perioperative Chemotherapy in Esophageal Cancer
7个月前
已完结
皖公网安备34019202002308
